pro-inflammatory mediators
[용어속성] Term
Dopamine Reduces SARS-CoV-2 Replication In Vitro through Downregulation of D2 Receptors and Upregulation of Type-I Interferons
도파민은 D2 수용체의 하향 조절 및 I형 인터페론의 상향 조절을 통해 시험관 내 SARS-CoV-2 복제를 감소시킵니다
Article
[키워드] administration
affected
Alter
alteration
Antiviral effect
antiviral effects
Calu
Calu-3
Calu-3 cell line
cell line
correlation
D2DR
Dopamine
doses
downregulating
downregulation
epithelial
Evidence
expression
Frame
host cell
IFN response
IFNs
immune response
immune responses
induce
Inflammasome
innate immune pathway
innate immune pathways
interferons
Invasion
ISG
ISGs
lung cells
mechanisms
mRNA
NLRP3
NLRP3 inflammasome
non-toxic
occur
pathway
Pathways
periphery
pro-inflammatory mediators
protein levels
quinpirole
quinpirole.
recent
receptor
reduce
reducing
Replication
robust
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2 replication
significantly
turn
upregulate
viral replication
while
[DOI] 10.3390/cells11101691 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/cells11101691 PMC 바로가기 [Article Type] Article
In Vitro SARS-CoV-2 Infection of Microvascular Endothelial Cells: Effect on Pro-Inflammatory Cytokine and Chemokine Release
미세혈관 내피 세포의 시험관 내 SARS-CoV-2 감염: 염증성 사이토카인 및 케모카인 방출에 대한 영향
Article
Published on
Journal: International Journal of Molecular Sciences [Category] COVID19(2023년), SARS, 치료기술,
Journal: International Journal of Molecular Sciences [Category] COVID19(2023년), SARS, 치료기술,
[키워드] ACE2 receptor
Activation
Analysis
chemokine
contribute
coronavirus disease
Coronavirus disease 2019
cytokine release
Cytokines
cytoplasm
days post-infection
dysfunction
Effect
electron
ELISA
endothelial
Endothelial cell
evaluated
expressed
expression
Human
Human Microvascular Endothelial Cells (HMEC-1)
IFN-α
IL-6
IL-6 level
IL-6 levels
IL-8
in vitro
Inflammatory mediators
mRNA
mRNA expression
pandemic
pro-inflammatory cytokine
pro-inflammatory cytokines
pro-inflammatory mediators
Release
RT-PCR
SARS-CoV-2
SARS-COV-2 infection
significantly higher
significantly lower
supernatant
supernatants
susceptible
TEM
These data
thrombotic
Thrombotic events
tissue
Tissue Factor
TNF-α
transmission electron microscopy
uninfected
viral amplification
Viral load
virion
virions
western blot
Western blot analysis
[DOI] 10.3390/ijms23074063 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/ijms23074063 PMC 바로가기 [Article Type] Article
Role of toll-like receptors in modulation of cytokine storm signaling in SARS-CoV-2-induced COVID-19
SARS-CoV-2로 유발된 COVID-19에서 사이토카인 폭풍 신호전달의 조절에서 톨 유사 수용체의 역할
Review
[키워드] Balanced
Blood
circulation
COVID-19
cytokine
Cytokine storm
Cytokine storms
Cytokines
death
driving
dsRNA
Elimination
endosomal
Factor
help
IL-1β
IL-4
IL-6
IL-8
Imbalance
immune regulation
individual
Inflammatory
inflammatory signaling
innate immune system
interferon
interleukin
killing
MAPK
membrane-bound
modulation
multiple organ failure
multiple organ failures
multiple-organ
multiple-organ failure
Necrosis
NF-κB
nonself
other organs
pathogen
Pro-inflammatory genes
pro-inflammatory mediator
pro-inflammatory mediators
recognize
recognizing
replicate
role
SARS-CoV-2
Signaling
ssRNA
ssRNA.
systemic circulation
the cytokine storm
TLR
TLR3
TLR4
TLR7
TLR7/8
TLR8
TLRs
Toll-like receptor
Toll-like receptors
Transcription
translation
TRIF
Tumor
tumor necrosis
tumor necrosis factor
[DOI] 10.1002/jmv.27405 PMC 바로가기 [Article Type] Review
[DOI] 10.1002/jmv.27405 PMC 바로가기 [Article Type] Review
Comparative Analysis of Circulating Levels of SARS-CoV-2 Antibodies and Inflammatory Mediators in Healthcare Workers and COVID-19 Patients
의료 종사자 및 COVID-19 환자의 SARS-CoV-2 항체 및 염증 매개체 순환 수준의 비교 분석
Article
[키워드] advance
anti-SARS-CoV-2
anti-SARS-CoV-2 antibodies
anti-SARS-CoV-2 antibody
antibodies
Antiviral
Asymptomatic
Brazil
CCL2
CCL2/MCP-1
chemokines
clinical evolution
Comparative
contribute
COVID-19
COVID-19 patient
Cytokines
cytokines/chemokines
dead
died
evaluate
explain
Factor
form
group
groups
HCW
healthcare
healthcare worker
Healthcare workers
Host
IFN-γ
IgA
IgG
IL-10
IL-6
Imbalance
individual
individuals
Inflammatory mediators
Inflammatory response
knowledge
Level
MCP-1
mediator
mediators
Mild
pathology
pathophysiology
patients
patients with COVID-19
pro-inflammatory mediator
pro-inflammatory mediators
recovered patient
SARS-CoV-2
sick
specific antibodies
specific antibody
symptomatic
the disease
TNF-α
worker
[DOI] 10.3390/v14030455 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/v14030455 PMC 바로가기 [Article Type] Article
Effects of IFIH1 rs1990760 variants on systemic inflammation and outcome in critically ill COVID-19 patients in an observational translational study
관찰 중개 연구에서 중환자 COVID-19 환자의 전신 염증 및 결과에 대한 IFIH1 rs1990760 변이체의 효과
Research Article
[키워드] 95% CI
95% confidence interval
analyzed
Anti-inflammatory
anti-inflammatory phenotype
applied
benefit
Blood
cause
Cell
changes in
clinical trial
clinical trials
coding
Cohort
Concentration
Corticosteroid
corticosteroid treatment
Corticosteroids
COVID
COVID-19
COVID-19 patient
COVID-19 patients
Critically ill
death
determine
Dexamethasone
discharge
distribution
drug
Effect
ENCODE
experiment
expression
Factor
funding
Gene Expression
greater
hazard ratio
healthy volunteer
healthy volunteers
help
hospital
host response
Human
ICU
IFIH1
IL-6
IL6
immune
Immune cell
immune cells
immune system
Impact
in-silico
increase in
individual
Infection
Inflammation
Inflammatory response
intensive care
intensive care unit
Laboratory
less
lower expression
Lung injury
MDA5
mechanical ventilation
mediators
moderate to severe
modulate
mononuclear cell
mononuclear cells
Mortality
outcome
outcomes
Pathways
Patient
patients
patients with moderate
peripheral
Peripheral blood
Peripheral blood mononuclear cells
pharmacogenomics
physician
populations
pro-inflammatory mediators
prospectively studied
Protein
recognize
Red
reduce
regulate
respond
risk
RNA
serum
Serum IL-6
severe COVID-19
Spain
steroid
Steroids
supported
survived
systemic inflammation
team
the patient
translational
treat
treated
Treatment
triggered
variant
variants
Variation
Viral
viral infections
virus
viruses
were measured
[DOI] 10.7554/eLife.73012 PMC 바로가기 [Article Type] Research Article
[DOI] 10.7554/eLife.73012 PMC 바로가기 [Article Type] Research Article
Direct comparison of different therapeutic cell types susceptibility to inflammatory cytokines associated with COVID-19 acute lung injury
COVID-19 급성 폐 손상과 관련된 염증성 사이토카인에 대한 다양한 치료 세포 유형 감수성의 직접 비교
Research
[키워드] acute lung injury
acute respiratory distress
acute respiratory distress syndrome
Alter
Analysis
ARDS
ARDS patients
Bone marrow
Cell
Cell therapy
cell type
cell viability
cells
characterized
clinical evaluation
clinical trial
clinically
Combination
conditioned media
COVID-19
COVID-19 ARDS patient
cytokine
Cytokine storm
Cytokines
Cytometry
deleterious effect
determine
Direct
Disease progression
dose
doses
dysregulated immune response
evaluate the effect
excluded
expression
Extracellular
Extracellular vesicles
Flow
flow cytometry
greater
high risk
IL-6
immunomodulatory
implicated
Infection
Inflammatory cytokine
Inflammatory cytokines
inflammatory mediator
Inflammatory mediators
mediators
Mesenchymal stromal cells
Mild
Mortality
not altered
Novel coronavirus
paracrine
pathology
Patient
pro-inflammatory mediator
pro-inflammatory mediators
progression
proteomic
receptor
receptors
respiratory distress
Respiratory distress syndrome
Result
severe ARDS
severe COVID-19
stem cell
stem cells
stromal cells
supplementary material
survival
susceptibility
syndrome
the cell
therapeutic
therapeutic efficacy
therapy
Treatment
umbilical
Vesicle
viability
were assessed
widespread
with COVID-19
[DOI] 10.1186/s13287-021-02699-7 PMC 바로가기 [Article Type] Research
[DOI] 10.1186/s13287-021-02699-7 PMC 바로가기 [Article Type] Research
Advances and highlights in biomarkers of allergic diseases
알레르기 질환 바이오마커의 발전과 하이라이트
Review
[키워드] addition
advance
allergen
allergen immunotherapy
allergic
allergic disease
allergic diseases
allergic rhinitis
anaphylaxis
approach
Asthma
asthmatic
asthmatic patient
Asthmatic patients
atopic dermatitis
Biomarker
Biomarkers
body fluid
body fluids
change
characterized
chronic urticaria
clinically
Clusters
collected
COVID-19
COVID-19 pandemic
Data analysis
diagnoses
Diagnosis
diagnosis and monitoring
eosinophils
epithelial
food allergies
fraction
help
highlight
hypersensitivity
immune response
Immunotherapy
include
information
Innate lymphoid cells
lymphoid cells
M2 macrophages
macrophages
management
Mast cells
mediators
microbiota
miRNAs
nitric oxide
noninvasive
omics technologies
outbreak
parameter
Perspective
plethora
point-of-care
Precision
precision medicine
presenting
pro-inflammatory mediators
quantified
recommendation
Research
robust
serum
sputum
Th2 cells
the disease
therapeutic targets
Treatment
urticaria
[DOI] 10.1111/all.15089 PMC 바로가기 [Article Type] Review
[DOI] 10.1111/all.15089 PMC 바로가기 [Article Type] Review
The triumvirate of NF-κB, inflammation and cytokine storm in COVID-19
Article
[키워드] accompanied
ACE2, angiotensin-converting enzyme II
Activation
acute respiratory distress
acute respiratory syndrome
ADAM17, metalloprotease 17
alarmin
ALI, acute lung injuries
approach
AT1R, activation of angiotensin-1-receptor
BAFFR, B-cell activating factor receptor
BLC, B-lymphocyte chemoattractant
bortezomib
c-AMP, cyclic adenosine phosphate
CASP3, caspase 3
CCL, chemokine ligand
CD40+, cluster of differentiation 40
CDC, Center for Disease Control and Prevention
chemokine
coronavirus disease
Coronavirus-2
Corticosteroid
cough
CoV, coronavirus
COVID-19
COVID-19, Coronavirus disease 2019
COX-2, cyclooxygenase-2
cross-talk
CRP C, reactive protein
CTLs, cytotoxic T lymphocytes
CXCL C-X-C, motif chemokine ligand
CXCL, C-X-C- motif chemokine
cytokine
Cytokine storm
Cytokine storm syndrome
DAMP, damage-associated molecular patterns (DAMP)
demonstrated
Dexamethasone
Diseases
Dyspnoea
dysregulated
Effectiveness
Enzymes
ERK1/2, extracellular signal-regulated kinases
expression
feature
Fever
GSDMD, Gasdermin
highlight
Host
Host immune response
IKK, IκB kinase
IL-1R, Interleukin 1 receptor (IL-1R)
IL, interleukin
immune dysregulation
immune system
Inflammation
Inflammatory cytokine
inhibitor
iNOS, nitric oxide synthase
IP-10, interferon-inducible protein 10
JAK, Janus kinase
JNK, Jun amino-terminal kinases
life-threatening
LPS, lipopolysaccharides
LTβR, Lymphotoxin-β receptor
manifestation
MAPK, Mitogen-activated protein kinase
MAPKs, mitogen-activated protein kinases
MCP-1, monocyte chemoattractant protein 1
MIG, monokine induced by interferon-γ
MIP-1α and MIP-1β, macrophage inflammatory protein 1α and 1β, respectively
monoclonal antibody
morbidity and mortality
multiple organ failure
NEMO, regulatory subunit IKKγ
NF-κB
NF-κB, nuclear factor kappa B cells
NF-κB
NK, natural killer
NO, Nitric Oxide
Novel coronavirus
nucleotide
offer
PAMPs, pathogen-associated molecular patterns
pathway
PKR, threonine-derived kinases
pro-inflammatory mediators
PTMs, post-translational modifications
RANK, receptor activator of NF-κB
Remdesivir
responsible
RSV, respiratory syncytial virus
SARS-CoV-2
SARS, Severe acute respiratory syndrome
Septic shock
Severe acute respiratory syndrome
severe complication
severe COVID-19 patients
Signal transduction
significant decrease
SMD, SOD, superoxide dismutase
STAT3, signal transduction activator of transcription factor 3
STING, stimulator of interferon genes
syndrome
systemic inflammation
Th, helper T cells
therapeutic intervention
therapeutic strategy
therapy
TLR-4, Toll-like receptor-4
TNF-α
TNF, Tumour Necrosis Factor
TNFR, tumour necrosis factor receptor
tyrosine
upregulating
VEGF, Vascular endothelial growth factor
[DOI] 10.1016/j.intimp.2021.108255 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.intimp.2021.108255 PMC 바로가기 [Article Type] Article
Endothelial Cell Activation by SARS-CoV-2 Spike S1 Protein: A Crosstalk between Endothelium and Innate Immune Cells
Article
[키워드] “cytokine storm”
activated
Activation
addressed
adhesion molecules
alteration
amplify
cell activation
chemokine
chemokines
Coagulopathy
Combination
conditioned
contributing to
COVID-19
Crosstalk
CXCL10/IP-10
Cytokines
decrease
endothelial activation
Endothelial cell
endothelial cells
Endothelial dysfunction
Endothelium
Evidence
expression
human lung
human monocyte-derived macrophage
hyperinflammatory state
ICAM-1
impairment
increased expression
Infection
Inflammatory response
Innate
Macrophage
macrophages
MDM
mechanism
medium
multi-organ failure
occur
Pathogenesis
pro-inflammatory mediator
pro-inflammatory mediators
Protein
prothrombotic state
released
S1 protein
SARS-CoV-2
severe COVID-19
spike
spike S1 protein
THBD
the disease
the S1 protein
the SARS-CoV-2
the spike protein
tissue
Vascular
vascular homeostasis
VCAM-1
[DOI] 10.3390/biomedicines9091220 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/biomedicines9091220 PMC 바로가기 [Article Type] Article